Abstract
Interleukin (IL)-33 is a recently identified pleiotropic cytokine, which can orchestrate complex innate and adaptive immune responses in immunity and disease. It has been characterized as a cytokine of the IL-1 family and affects a wide range of immune cells by signalling through its receptor ST2L. Accumulating evidence suggests a crucial role of IL-33/ST2 in inducing and modifying host immune responses against a variety of pathogens including parasites, bacteria, viruses and fungi as well as sterile insults of both endogenous and exogenous source. In this review, we endeavour to give a comprehensive overview of the current knowledge about the role of IL-33 and its receptor ST2 in host defence against infections.
Similar content being viewed by others
References
Albonico M, Savioli L (1997) Hookworm infection and disease: advances for control. Ann Ist Super Sanita 33:567–579
Ali S, Mohs A, Thomas M et al (2011) The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol 187:1609–1616
Allakhverdi Z, Smith DE, Comeau MR et al (2007) Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051–2054
Alves-Filho JC, Sonego F, Souto FO et al (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16:708–712
Antignano F, Mullaly SC, Burrows K et al (2011) Trichuris muris infection: a model of type 2 immunity and inflammation in the gut. J Vis Exp pii: 2774
Baekkevold ES, Roussigne M, Yamanaka T et al (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163:69–79
Becerra A, Warke RV, de Bosch N et al (2008) Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 41:114–120
Besnard AG, Togbe D, Guillou N et al (2011) IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 41:1675–1686
Bonilla WV, Frohlich A, Senn K et al (2012) The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science 335:984–989
Bourgeois E, Van LP, Samson M et al (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 39:1046–1055
Brough D, Le Feuvre RA, Iwakura Y et al (2002) Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol Cell Neurosci 19:272–280
Carriere V, Roussel L, Ortega N et al (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 104:282–287
Cayrol C, Girard JP (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 106:9021–9026
Chang YJ, Kim HY, Albacker et al (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12:631–638
Chaturvedi U, Nagar R, Shrivastava R (2006) Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47:155–166
Enoksson M, Lyberg K, Moller-Westerberg C et al (2011) Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 186:2523–2528
Espinassous Q, Garcia-de-Paco E, Garcia-Verdugo I et al (2009) IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J Immunol 183:1446–1455
Gillibert-Duplantier J, Duthey B, Sisirak V et al (2012) Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. Oncogene 31:3516–3524
Guo L, Wei G, Zhu J et al (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci USA 106:13463–13468
Hansen JD, Vojtech LN, Laing KJ (2011) Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol 35:886–897
Haraldsen G, Balogh J, Pollheimer J et al (2009) Interleukin-33—cytokine of dual function or novel alarmin? Trends Immunol 30:227–233
Hayakawa H, Hayakawa M, Kume A et al (2007) Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282:26369–26380
Hazlett LD, McClellan SA, Barrett RP et al (2010) IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 51:1524–1532
Houghton-Trivino N, Salgado DM, Rodriguez JA et al (2010) Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation. J Gen Virol 91(Pt 3):697–706
Hudson CA, Christophi GP, Gruber RC et al (2008) Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84:631–643
Huising MO, Stet RJ, Savelkoul HF et al (2004) The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev Comp Immunol 28:395–413
Humphreys NE, Xu D, Hepworth MR et al (2008) IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 180:2443–2449
Jones LA, Roberts F, Nickdel MB et al (2010) IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol 40:426–436
Kakkar R, Hei H, Dobner S et al (2012) Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 287:6941–6948
Keller M, Ruegg A, Werner S et al (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818–831
Klune JR, Dhupar R, Cardinal J et al (2008) HMGB1: endogenous danger signaling. Mol Med 14:476–484
Komai-Koma M, Xu D, Li Y et al (2007) IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37:2779–2786
Komai-Koma M, Gilchrist DS, McKenzie AN et al (2011) IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol 186:2584–2591
Kouzaki H, Iijima K, Kobayashi T et al (2011) The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 186:4375–4387
Kropf P, Bickle Q, Herath S et al (2002) Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection. Eur J Immunol 32:2450–2459
Kropf P, Herath S, Klemenz R et al (2003) Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection. Infect Immun 71:1961–1971
Kurowska-Stolarska M, Stolarski B, Kewin P et al (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183:6469–6477
Le Goffic R, Arshad MI, Rauch M et al (2011) Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol 45:1125–1132
Le HT, Tran VG, Kim W et al (2012) IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals. J Immunol 189:287–295
Lefrancais E, Roga S, Gautier V et al (2012) IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 109:1673–1678
Liew FY (2012) IL-33: a Janus cytokine. Ann Rheum Dis 71(Suppl 2):i101–i104
Liew FY, Pitman NI, McInnes IB (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10:103–110
Lohning M, Stroehmann A, Coyle AJ et al (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95:6930–6935
Luthi AU, Cullen SP, McNeela EA et al (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84–98
Medzhitov R, Schneider DS, Soares MP (2012) Disease tolerance as a defense strategy. Science 335:936–941
Monticelli LA, Sonnenberg GF, Abt MC et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045–1054
Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS One 3:e3331
Nagata A, Takezako N, Tamemoto H et al (2012) Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells. Cell Mol Immunol 9:399–409
Neill DR, Wong SH, Bellosi A et al (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367–1370
Nelson MP, Christmann BS, Werner JL et al (2011) IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 186:2372–2381
Nile CJ, Barksby E, Jitprasertwong P et al (2010) Expression and regulation of interleukin-33 in human monocytes. Immunology 130:172–180
Oboki K, Ohno T, Kajiwara N et al (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 107:18581–18586
Onda H, Kasuya H, Takakura K et al (1999) Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19:1279–1288
Paul WE, Zhu J (2010) How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10:225–235
Pecaric-Petkovic T, Didichenko SA, Kaempfer S et al (2009) Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113:1526–1534
Peiris JS, Cheung CY, Leung CY et al (2009) Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol 30:574–584
Pichery M, Mirey E, Mercier P et al (2012) Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 188:3488–3495
Polumuri SK, Jayakar GG, Shirey KA et al (2012) Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J Immunol 189:50–60
Price AE, Liang HE, Sullivan BM et al (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107:11489–11494
Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264–296
Schlenke TA, Begun DJ (2003) Natural selection drives Drosophila immune system evolution. Genetics 164:1471–1480
Schmitz J, Owyang A, Oldham E et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490
Shimosato T, Fujimoto M, Tohno M et al (2010) CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9. Biochem Biophys Res Commun 394:81–86
Smith DE (2010) IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 40:200–208
Smithgall MD, Comeau MR, Yoon BR et al (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20:1019–1030
Spits H, Cupedo T (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30:647–675
Stein C, Caccamo M, Laird G et al (2007) Conservation and divergence of gene families encoding components of innate immune response systems in zebrafish. Genome Biol 8:R251
Suzukawa M, Iikura M, Koketsu R et al (2008) An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 181:5981–5989
Takezako N, Hayakawa M, Hayakawa H et al (2006) ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun 341:425–432
Tominaga S, Jenkins NA, Gilbert DJ et al (1991) Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping. Biochim Biophys Acta 1090:1–8
Wagenaar JF, Gasem MH, Goris MG et al (2009) Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis 3:e453
Wieland CW, van der Windt GJ, Florquin S et al (2009) ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis. Microbes Infect 11:524–530
Wilhelm C, Stockinger B (2011) Innate lymphoid cells and type 2 (th2) mediated immune responses—pathogenic or beneficial? Front Immunol 2:68
Xu D, Chan WL, Leung BP et al (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187:787–794
Xu D, Jiang HR, Kewin P et al (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 105:10913–10918
Yanagisawa K, Takagi T, Tsukamoto T et al (1993) Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 318:83–87
Yang Q, Li G, Zhu Y et al (2011) IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol 41:3351–3360
Yasuda K, Muto T, Kawagoe T et al (2012) Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci USA 109:3451–3456
Zhang L, Lu R, Zhao G et al (2011) TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. Int J Biochem Cell Biol 43:1383–1391
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sattler, S., Smits, H.H., Xu, D. et al. The Evolutionary Role of the IL-33/ST2 System in Host Immune Defence. Arch. Immunol. Ther. Exp. 61, 107–117 (2013). https://doi.org/10.1007/s00005-012-0208-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-012-0208-8